drugset / Trial / NCT05492487

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

NCT05492487

Phase 2 Unknown 60 enrolled KK Women's and Children's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators' objective is to determine the regression rate, side effects and acceptability of Mirena compared to megace in the treatment of atypical endometrial hyperplasia among women desiring fertility.

Timeline

Start
2020-01-03
Primary completion
2023-03-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 52 mg Other
Subject Megestrol Acetate Other / unclassified 160 mg Oral